Clinical and Molecular Characterization of ALG1-CDG

Radhika Dhamija; Chelsea Chambers

doi:10.15844/pedneurbriefs-30-2-5

Clinical and Molecular Characterization of ALG1-CDG

Pediatric Neurology Briefs

Volume 30 (2016): Issue 2

By: Radhika Dhamija and Chelsea Chambers

Open Access

|Apr 2016

Ng BG Shiryaev SA Rymen D Eklund EA ALG1-CDG: Clinical and Molecular Characterizattion of 39 Unreported Patients H Mutat 2016 March 2 Epub ahead of print 10.1002/humu.22983 26931382
Open DOI Search in Google Scholar Back to article
Freeze HH Eklund EA Ng BG Patterson MC Neurological aspects of human glycosylation disorders Annu Rev Neurosci 2015 Jul 38 1 105 25 10.1146/annurev-neuro-071714-034019 25840006
Open DOI Search in Google Scholar Back to article
Freeze HH Eklund EA Ng BG Patterson MC Neurology of inherited glycosylation disorders Lancet Neurol 2012 May 11 5 453 66 10.1016/S1474-4422(12)70040-6 22516080
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-30-2-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 14 - 14

Submitted on: Mar 25, 2016

Accepted on: Apr 1, 2016

Published on: Apr 5, 2016

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Asparagine-Linked Glycosylation Protein 1,

CDG,

Carbohydrate-Deficient Transferrin

© 2016 Radhika Dhamija, Chelsea Chambers, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 30 (2016): Issue 2